NCT05547529View on ClinicalTrials.gov

The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

September 14, 2022

Primary Completion Date

September 14, 2025

Study Completion Date

September 14, 2027

Conditions
Esophageal Cancer
Interventions
PROCEDURE

Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.

Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.

PROCEDURE

Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy

Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy

Trial Locations (1)

115478

RECRUITING

N.N. Blokhin National Medical Research Center of Oncology, Moscow

All Listed Sponsors
lead

Blokhin's Russian Cancer Research Center

OTHER